EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Highly carbapenem-resistant Achromobacter xylosoxidans harboring bla NDM-1 in Myanmar

Maiko Kirikae, Satoshi Oshiro, Satomi Takei, Naeko Mizutani, Atsuo Itakura, Pan Ei Soe, Thi Thi Htoon, Swe Setk, Htay Htay Tin, Teruo Kirikae, Tatsuya Tada iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.00080-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Maiko Kirikae und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Achromobacter denitrificans, Anti-Bacterial Agents, beta-Lactamases, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Achromobacter xylosoxidans is a multidrug-resistant, non-glucose-fermenting, gram-negative bacterium with intrinsic resistance to many antimicrobial agents. Between 2016 and 2017, five A. xylosoxidans isolates were obtained from five patients at three hospitals in Myanmar. Minimum inhibitory concentrations (MICs) against various antimicrobial agents were determined using the microdilution method. Whole genome sequencing was performed with the MiSeq and MinION platforms. Resistance genes and their surrounding structures were identified and compared. All five isolates were resistant to amikacin and aztreonam. Among them, one isolate, MyNCGM749, was resistant to imipenem and meropenem with MICs of 256 µg/mL and amikacin with MIC of >512 µg/mL but intermediate to ciprofloxacin with MIC of 2 µg/mL. The isolate carried bla NDM-1 encoding metallo-β-lactamase, bla PSE-1 encoding extended-spectrum-β-lactamase, and bla OXA-114 (encoding intrinsic -β-lactamase present in A. xylosoxidans ), along with five aminoglycoside modification encoding genes including aac(6')-Ib , aph (6)-Id , aph(3'')-Ib , ant(4')-Iib , and aph(3')-VI on its chromosome. The genetic structure surrounding bla NDM-1 contained four IS 91 elements identical to those found in carbapenem-resistant Pseudomonas asiatica isolates in Myanmar. This is the first report of A. xylosoxidans in Myanmar. Although A. xylosoxidans harboring bla NDM-1 has been reported in a single strain from India, its genomic details have not been previously described. This study indicates that the bla NDM-1 -containing structure flanked by IS 91 is spreading among gram-negative, non-glucose-fermenting bacteria in Myanmar and neighboring countries. IMPORTANCE Achromobacter species were originally environmental organisms that became opportunistic pathogens with multidrug resistance. Achromobacter xylosoxidans is associated with nosocomially acquired infections affecting multiple organ systems, including the respiratory and urinary tracts, and, less commonly, the cardiovascular and central nervous systems. To date, carbapenem-resistant A. xylosoxidans carrying carbapenemase-encoding genes has been reported in several countries, including Greece, India, Italy, Japan, Korea, Libya, and the Netherlands. In this molecular epidemiological study on A. xylosoxidans in Myanmar, we identified the genomic structure surrounding bla NDM-1 , flanked by IS 91 . This structure may facilitate the spread of non-glucose-fermenting gram-negative bacteria, such as Achromobacter , Pseudomonas, and Stenotrophomonas species, in Asian countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Achromobacter denitrificansAnti-Bacterial Agentsbeta-LactamasesGram-Negative Bacterial InfectionsCarbapenemsDrug Resistance, Multiple, BacterialHumansMicrobial Sensitivity TestsMyanmarWhole Genome SequencingBacterial ProteinsMale

Stichwörter der Autor:innen

Achromobacter xylosoxidansblaNDM-1carbapenemasemultidrug resistance

Substanzen

Anti-Bacterial Agentsbeta-Lactamasesbeta-lactamase NDM-1CarbapenemsBacterial Proteins

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Juntendo Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan.
  • Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • National Health Laboratory, Yangon, Myanmar.
  • Department of Microbiology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Department of Clinical Laboratory Technology, Juntendo University Faculty of Medical Science, Chiba, Japan.

ORCID-Profile: Tatsuya Tada

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Kirikae, M., Oshiro, S., Takei, S., Mizutani, N., Itakura, A., Soe, P. E., Htoon, T. T., Setk, S., Tin, H. H., Kirikae, T., & Tada, T. (2025). Highly carbapenem-resistant Achromobacter xylosoxidans harboring bla NDM-1 in Myanmar. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00080-25

Vancouver

Kirikae M, Oshiro S, Takei S, Mizutani N, Itakura A, Soe PE, et al. Highly carbapenem-resistant Achromobacter xylosoxidans harboring bla NDM-1 in Myanmar. Microbiology Spectrum. 2025. doi:10.1128/spectrum.00080-25

BibTeX
@article{Kirikae2025,
  author = {Kirikae, Maiko and Oshiro, Satoshi and Takei, Satomi and Mizutani, Naeko and Itakura, Atsuo and Soe, Pan Ei and Htoon, Thi Thi and Setk, Swe and Tin, Htay Htay and Kirikae, Teruo and Tada, Tatsuya},
  title = {Highly carbapenem-resistant Achromobacter xylosoxidans harboring bla NDM-1 in Myanmar},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.00080-25}
}
Kostenlos starten →